Watchlist Price Alert

Ensysce Biosciences Inc. (ENSC)

NASDAQ: ENSC · Real-Time Price · USD

2.60

-0.37 (-12.46%)

At close: May 02, 2025, 3:59 PM

2.60

-0.14%

After-hours: May 02, 2025, 05:52 PM EDT

Ensysce Biosciences Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Revenue	n/a	2.23M	2.52M	3.53M	3.93M	1.76M	n/a	n/a
Cost of Revenue	n/a	7.59M	19.84M	151.00	1.37M	3.33M	1.56M	n/a
Gross Profit	n/a	-5.36M	-17.31M	3.53M	2.56M	-1.56M	-1.56M	n/a
Operating Income	-6,730.1B	-10.72M	-24.22M	-19.87M	-1.61M	-3.33M	-959.24K	-146.7K
Interest Income	n/a	n/a	1.25M	3.22M	719.65K	4.25M	3.63M	n/a
Pretax Income	-7,987.2B	-10.63M	-24.21M	-29.15M	-160.88K	921.15K	2.68M	-27.56K
Net Income	-7,987.2B	-10.61M	-24.96M	-29.15M	-938.73K	1.48M	-1.34M	-31.19K
Selling & General & Admin	4,720.7B	5.36M	6.91M	18.71M	1.15M	3.33M	1.56M	146.69K
Research & Development	7,219.4B	7.59M	19.84M	4.69M	4.39M	3.4M	n/a	n/a
Other Expenses	n/a	-7.59M	-2.52M	-3.53M	-3.93M	n/a	600K	n/a
Operating Expenses	11,940.2B	5.36M	24.22M	19.87M	1.61M	3.33M	959.25K	146.69K
Interest Expense	-1,290.4B	353.94K	109.53K	1.3M	995.5K	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	-3.6M	n/a	n/a
Cost & Expenses	n/a	12.95M	24.22M	19.87M	1.61M	3.33M	959.24K	146.69K
Income Tax Expense	n/a	n/a	753.88K	-151	777.85K	-555.2K	553.92K	3.63K
Shares Outstanding (Basic)	1.75M	2.26M	179.93K	84.02K	65.7K	6.09M	6.01M	5.98M
Shares Outstanding (Diluted)	1.75M	2.26M	179.93K	84.02K	68.78K	6.09M	6.01M	5.98M
EPS (Basic)	-4.57M	-4.69	-138.73	-346.9	-14.29	0.24	-0.22	-0.01
EPS (Diluted)	-4.57M	-4.69	-138.73	-346.9	-13.65	0.24	-0.22	-0.01
EBITDA	-6,730.1B	-10.72M	-24.22M	-19.87M	-1.61M	921.15K	2.68M	-27.55K
EBIT	-9,277.7B	-10.72M	-24.22M	-19.87M	-1.61M	921.15K	2.68M	-27.55K
Depreciation & Amortization	n/a	-3	151.00	151.00	201.00	201.00	161.14K	n/a